Laser treatment for snoring
Safety and Efficacy of Different Modes of Er:YAG Laser Treatment for Snoring in Comparison With Placebo
This study is testing two different types of laser treatments for snoring to see which one works better than a fake treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cooperativa de Ensino Superior, Politécnico e Universitário Academic / other |
| Locations | 1 site (Porto) |
| Trial ID | NCT03947424 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of two modes of Er:YAG laser treatment for snoring compared to a sham treatment. Participants will receive either the long-pulse mode or the proprietary SMOOTH mode of the laser, with the aim of determining which method yields better clinical outcomes. The study will involve a randomized design to ensure unbiased results and will assess the impact of the treatments on snoring severity. The trial will also require partner input to confirm the diagnosis of snoring or apnea.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with a diagnosis of snoring or sleep apnea and an apnea-hypopnea index of less than 30.
Not a fit: Patients with significant nasal stenosis, throat infections, or other severe obstructive conditions may not benefit from this treatment.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce snoring and improve sleep quality for affected patients.
How similar studies have performed: While laser treatments for snoring are emerging, this specific comparison of Er:YAG laser modes is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed Informed consent form * Diagnosis of snoring/apnea including partner information * Age greater than 18 years. * Apnea-Hypopnea index (AHI) less than 30. * No significant nasal stenosis. * Bed partner present Exclusion Criteria: * People who refuse to participate in the study * Presence of concomitant disorders and/or diseases * Infections in the throat * current use of photosensitive drugs * pregnancy * scarring in the throat * acute pollen allergies * epilepsy * People starting with an extreme diet or weight loss plan * Patients who do not want to follow post treatment recommendation concerning food and drinks intake * Larynx obstruction (floppy epiglottis) * Oropharynx obstruction caused by palatine tonsils (\>50%).
Where this trial is running
Porto
- Instituto Universitário de Ciências da Saude, CESPU — Porto, Portugal (Recruiting)
Study contacts
- Principal investigator: Luis Monteiro, DMD, PhD — Instituto Universitário de Ciências da Saude, CESPU
- Study coordinator: Luis Monteiro, DMD, PhD
- Email: luis.monteiro@iucs.cespu.pt
- Phone: +351 919120226
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.